Related Experiment Video
Updated: Dec 29, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Pum2-Mff axis fine-tunes mitochondrial quality control in acute ischemic kidney injury
Jin Wang1, Pingjun Zhu1, Sam Toan2
1Medical School of Chinese PLA, Chinese PLA General Hospital, Beijing, China.
Abstract:
Mitochondrial fission factor (Mff) has been demonstrated to play a role in the activation of mitochondrial cleavage and mitochondrial death, denoting its role in the regulation of mitochondrial quality control. Recent evidence suggested that the mRNA translation of Mff is under the negative regulation by the RNA-binding protein Pumilio2 (Pum2). This study was designed to examine the role of Pum2 and Mff in the governance of mitochondrial quality control in a murine model of acute ischemic kidney injury. Our results indicated that genetic deletion of Mff overtly attenuated ischemic acute kidney injury (AKI)-induced renal failure through inhibition of pro-inflammatory response, tubular oxidative stress, and ultimately cell death in the kidney. Furthermore, Mff inhibition effectively preserved mitochondrial homeostasis through amelioration of mitochondrial mitosis, restoration of Sirt1/3 expression, and boost of mitochondrial respiration. Western blot analysis revealed that levels of Pum2 were significantly downregulated by ischemic AKI, inversely coinciding with levels of Mff. Overexpression of Pum2 reduced ischemic AKI-mediated Mff upregulation and offered protection on renal tubules through modulation of mitochondrial quality control. Taken together, our data have unveiled the molecular mechanism of the Pum2-Mff axis in mitochondrial quality control in a mouse model of ischemic AKI. These data indicated the therapeutic potential of Pum2 activation and Mff inhibition in the management of ischemic AKI.
Insights
Mitochondrial fission factor (Mff) deletion protected against kidney injury by improving mitochondrial function. Pumilio2 (Pum2) protein levels decreased during injury, and its restoration offered protection by regulating Mff.
Area of Science:
- Mitochondrial biology
- Renal pathophysiology
- Molecular mechanisms of cell injury
Background:
- Mitochondrial fission factor (Mff) regulates mitochondrial quality control, including cleavage and cell death.
- RNA-binding protein Pumilio2 (Pum2) negatively regulates Mff mRNA translation.
- The interplay between Pum2 and Mff in acute kidney injury (AKI) remains underexplored.
Purpose of the Study:
- To investigate the roles of Pum2 and Mff in mitochondrial quality control during ischemic AKI in a murine model.
- To elucidate the molecular mechanisms underlying the Pum2-Mff axis in ischemic AKI.
Main Methods:
- Utilized a murine model of ischemic acute kidney injury (AKI).
- Investigated the effects of Mff genetic deletion and Pum2 overexpression on renal function and mitochondrial homeostasis.
- Employed Western blot analysis to assess protein levels of Pum2 and Mff.
- Evaluated inflammatory response, oxidative stress, tubular cell death, mitochondrial mitosis, Sirt1/3 expression, and mitochondrial respiration.
Main Results:
- Genetic deletion of Mff attenuated ischemic AKI-induced renal failure by inhibiting inflammation, oxidative stress, and cell death.
- Mff inhibition preserved mitochondrial homeostasis, improving mitochondrial mitosis, Sirt1/3 expression, and respiration.
- Ischemic AKI downregulated Pum2 while upregulating Mff; Pum2 overexpression counteracted Mff upregulation and protected renal tubules.
- The Pum2-Mff axis was identified as a key regulator of mitochondrial quality control in ischemic AKI.
Conclusions:
- The Pum2-Mff axis plays a critical role in regulating mitochondrial quality control during ischemic AKI.
- Mff inhibition and Pum2 activation demonstrate therapeutic potential for managing ischemic AKI.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations

